166 related articles for article (PubMed ID: 30925056)
1. Novel Pyrazolo[4,3- d]pyrimidine as Potent and Orally Active Inducible Nitric Oxide Synthase (iNOS) Dimerization Inhibitor with Efficacy in Rheumatoid Arthritis Mouse Model.
Shi JB; Chen LZ; Wang BS; Huang X; Jiao MM; Liu MM; Tang WJ; Liu XH
J Med Chem; 2019 Apr; 62(8):4013-4031. PubMed ID: 30925056
[TBL] [Abstract][Full Text] [Related]
2. Discovery and development of novel pyrimidine and pyrazolo/thieno-fused pyrimidine derivatives as potent and orally active inducible nitric oxide synthase dimerization inhibitor with efficacy for arthritis.
Chen LZ; Shu HY; Wu J; Yu YL; Ma D; Huang X; Liu MM; Liu XH; Shi JB
Eur J Med Chem; 2021 Mar; 213():113174. PubMed ID: 33515864
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and molecular docking of novel D-ring substituted steroidal 4,5-dihydropyrazole thiazole derivatives that act as iNOS/COX-2 inhibitors with potent anti-inflammatory activity against LPS-induced RAW264.7 macrophage cells.
Fang S; Huang X; Cai F; Qiu G; Lin F; Cai X
J Steroid Biochem Mol Biol; 2024 Jun; 240():106478. PubMed ID: 38430971
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of new disubstituted benzoxazolone derivatives that act as iNOS inhibitors with potent anti-inflammatory activity against LPS-induced acute lung injury (ALI).
Tang L; Gao XH; Zhao B; Luo JR; Shi XY; Ge R; Ban SR; Li QS
Bioorg Med Chem; 2020 Nov; 28(21):115733. PubMed ID: 33065432
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Pyrazolo[4,3-
Tseng CH; Tung CW; Peng SI; Chen YL; Tzeng CC; Cheng CM
Molecules; 2018 Apr; 23(5):. PubMed ID: 29710774
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory efficacy and relevant SAR investigations of novel chiral pyrazolo isoquinoline derivatives: Design, synthesis, in-vitro, in-vivo, and computational studies targeting iNOS.
Akhtar M; Niu J; Zhu Y; Luo Z; Tian T; Dong Y; Wang Y; Fareed MS; Lin L
Eur J Med Chem; 2023 Aug; 256():115412. PubMed ID: 37146344
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and investigation of potential anti-inflammatory activity of O-alkyl and O-benzyl hesperetin derivatives.
Huang AL; Zhang YL; Ding HW; Li B; Huang C; Meng XM; Li J
Int Immunopharmacol; 2018 Aug; 61():82-91. PubMed ID: 29852476
[TBL] [Abstract][Full Text] [Related]
8. PPA250 [3-(2,4-difluorophenyl)-6-[2-[4-(1H-imidazol-1-ylmethyl) phenoxy]ethoxy]-2-phenylpyridine], a novel orally effective inhibitor of the dimerization of inducible nitric-oxide synthase, exhibits an anti-inflammatory effect in animal models of chronic arthritis.
Ohtsuka M; Konno F; Honda H; Oikawa T; Ishikawa M; Iwase N; Isomae K; Ishii F; Hemmi H; Sato S
J Pharmacol Exp Ther; 2002 Oct; 303(1):52-7. PubMed ID: 12235232
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of triarylpyrazole derivatives on LPS-induced nitric oxide and PGE
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Lee H; Choi J; Kim TW; Shin JS; Lee HH; Kim HK; Lee KT; Baek D
Bioorg Med Chem Lett; 2020 Feb; 30(4):126884. PubMed ID: 31879211
[TBL] [Abstract][Full Text] [Related]
10. Tanzawaic acid derivatives from a marine isolate of Penicillium sp. (SF-6013) with anti-inflammatory and PTP1B inhibitory activities.
Quang TH; Ngan NTT; Ko W; Kim DC; Yoon CS; Sohn JH; Yim JH; Kim YC; Oh H
Bioorg Med Chem Lett; 2014 Dec; 24(24):5787-5791. PubMed ID: 25453820
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents.
Zhang Y; Luo L; Han C; Lv H; Chen D; Shen G; Wu K; Pan S; Ye F
Molecules; 2017 Nov; 22(11):. PubMed ID: 29137170
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory and anti-arthritic effects of new synthetic 3-(4-hydroxyphenyl)-4-(4-thiomethoxyphenyl)-1H-pyrrole-2,5-dione.
Shin JS; Noh YS; Yoo MS; Lee JY; Cho YW; Lee KT
Bioorg Med Chem Lett; 2012 Mar; 22(6):2221-5. PubMed ID: 22349257
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of novel D-ring substituted steroidal pyrazolines as potential anti-inflammatory agents.
Cai X; Zhao S; Cai D; Zheng J; Zhu Z; Wei D; Zheng Z; Zhu H; Chen Y
Steroids; 2019 Jun; 146():70-78. PubMed ID: 30951758
[TBL] [Abstract][Full Text] [Related]
14. Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.
Bonnefous C; Payne JE; Roppe J; Zhuang H; Chen X; Symons KT; Nguyen PM; Sablad M; Rozenkrants N; Zhang Y; Wang L; Severance D; Walsh JP; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND
J Med Chem; 2009 May; 52(9):3047-62. PubMed ID: 19374401
[TBL] [Abstract][Full Text] [Related]
15. Withapubesides A-D: natural inducible nitric oxide synthase (iNOS) inhibitors from Physalis pubescens.
Xia GY; Yao T; Zhang BY; Li Y; Kang N; Cao SJ; Ding LQ; Chen LX; Qiu F
Org Biomol Chem; 2017 Dec; 15(47):10016-10023. PubMed ID: 29164214
[TBL] [Abstract][Full Text] [Related]
16. Pseudoguaianelactones A-C: three unusual sesquiterpenoids from Lindera glauca with anti-inflammatory activities by inhibiting the LPS-induced expression of iNOS and COX-2.
Ruan QF; Jiang SQ; Zheng XY; Tang YQ; Yang B; Yi T; Jin J; Cui H; Zhao Z
Chem Commun (Camb); 2020 Feb; 56(10):1517-1520. PubMed ID: 31919484
[TBL] [Abstract][Full Text] [Related]
17. Novel pyrazolopyrimidine derivatives targeting COXs and iNOS enzymes; design, synthesis and biological evaluation as potential anti-inflammatory agents.
Abdelazeem AH; Abdelatef SA; El-Saadi MT; Omar HA; Khan SI; McCurdy CR; El-Moghazy SM
Eur J Pharm Sci; 2014 Oct; 62():197-211. PubMed ID: 24907682
[TBL] [Abstract][Full Text] [Related]
18. The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).
Cheshire DR; Åberg A; Andersson GM; Andrews G; Beaton HG; Birkinshaw TN; Boughton-Smith N; Connolly S; Cook TR; Cooper A; Cooper SL; Cox D; Dixon J; Gensmantel N; Hamley PJ; Harrison R; Hartopp P; Käck H; Leeson PD; Luker T; Mete A; Millichip I; Nicholls DJ; Pimm AD; St-Gallay SA; Wallace AV
Bioorg Med Chem Lett; 2011 Apr; 21(8):2468-71. PubMed ID: 21398123
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1beta through suppression of NF-kappaB activation by 3-(1'-1'-dimethyl-allyl)-6-hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L.
Raghav SK; Gupta B; Shrivastava A; Das HR
Eur J Pharmacol; 2007 Mar; 560(1):69-80. PubMed ID: 17292351
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect of the six compounds isolated from Nauclea officinalis Pierrc ex Pitard, and molecular mechanism of strictosamide via suppressing the NF-κB and MAPK signaling pathway in LPS-induced RAW 264.7 macrophages.
Li D; Chen J; Ye J; Zhai X; Song J; Jiang C; Wang J; Zhang H; Jia X; Zhu F
J Ethnopharmacol; 2017 Jan; 196():66-74. PubMed ID: 27989509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
